Related Experiment Video
Updated: Aug 6, 2026
06:04
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
Published on: March 6, 2018
Transurethral resection of benign prostatic hyperplasia using a vaporizing resecting loop, UROloop
T Morita1, K Matsuki, N Miyanaga
1Department of Urology, Tsukuba Gakuen Hospital.
Hinyokika Kiyo. Acta Urologica Japonica
|April 23, 1999
Summary
A new electrosurgical device, UROloop, effectively treats benign prostatic hyperplasia (BPH) with transurethral prostatectomy (TUR-P). Patients experienced significant symptom improvement and enhanced urinary flow with minimal complications.
Area of Science:
- Urology
- Minimally Invasive Surgery
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- New electrosurgical instruments offer potential advancements in BPH treatment.
Purpose of the Study:
- To evaluate the efficacy and safety of transurethral prostatectomy (TUR-P) using the novel UROloop electrosurgical device for BPH treatment.
- To assess clinical outcomes and urodynamic parameters post-procedure.
Main Methods:
- A prospective study involving 24 male patients with BPH undergoing TUR-P with the UROloop device.
- Pre- and postoperative evaluation included International Prostate Symptom Score (IPSS), peak flow rate (PFR), and postvoid residual urine (PVR).
Main Results:
- Significant improvement in IPSS scores from 15.4 to 4.3 at 12 weeks post-TUR-P (p = 0.0002).
- Urodynamic parameters showed significant improvement: PFR increased by 117%, and PVR decreased from 65.4 ml to 15.2 ml.
- Minimal changes in serum sodium and hemoglobin levels, with no severe complications observed.
Conclusions:
- Transurethral prostatectomy using the UROloop device provides sustained clinical improvement for BPH patients.
- The UROloop procedure demonstrates a favorable safety profile with minimal morbidity, confirming its usefulness as an endoscopic treatment option.
